about
Proton pump inhibitors for functional dyspepsiaENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromesProton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazoleNutritional neuropathiesWidespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumoniaProton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?Perils and pitfalls of long-term effects of proton pump inhibitors.Proton pump inhibitor discontinuation in long-term care.Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting SystemRisk of fracture and the concomitant use of bisphosphonates with osteoporosis-inducing medications.The impact of proton pump inhibitors on the human gastrointestinal microbiomeRepositioning proton pump inhibitors as anticancer drugs by targeting the thioesterase domain of human fatty acid synthaseProton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?Prevention of NSAID-associated gastroduodenal injury in healthy volunteers-a randomized, double-blind, multicenter study comparing DA-9601 with misoprostol.Unmet Needs in the Treatment of Gastroesophageal Reflux Disease.Pediatric patients with dyspepsia have chronic symptoms, anxiety, and lower quality of life as adolescents and adults.Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled triaUse of proton pump inhibitors is associated with fractures in young adults: a population-based study.Risk of community-acquired pneumonia in patients with a diagnosis of pernicious anemia: a population-based retrospective cohort study.Intestinal GPS: bile and bicarbonate control cyclic di-GMP to provide Vibrio cholerae spatial cues within the small intestine.Proton pump inhibitors for functional dyspepsia.Proton pump inhibitor associated hypomagnasaemia - a cause for concern?Association Between the Use of Proton Pump Inhibitors and the Risk of ESRD in Renal Diseases: A Population-Based, Case-Control Study.A new method for determining gastric acid output using a wireless pH-sensing capsule.Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's HospitalsDiscontinuation of low-dose acetylsalicylic acid therapy in UK primary care: incidence and predictors in patients with cardiovascular disease.Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients.Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.Effects of CYP2C19 Genetic Polymorphisms on PK/PD Responses of Omeprazole in Korean Healthy Volunteers.Review of proton pump inhibitors for the initial treatment of heartburn: is there a dose ceiling effect?Gastrointestinal prophylaxis in neurocritical care.HZT-501 (DUEXIS(®); ibuprofen 800 mg/famotidine 26.6 mg) gastrointestinal protection in the treatment of the signs and symptoms of rheumatoid arthritis and osteoarthritis.Prescribing proton pump inhibitors: is it time to pause and rethink?Endotherapy for Barrett's esophagus.Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?Zollinger-Ellison syndrome: recent advances and controversies.Does gastric acid suppression affect sunitinib efficacy in patients with advanced or metastatic renal cell cancer?Prokinetic agents and laryngopharyngeal reflux disease: Prokinetic agents and laryngopharyngeal reflux disease: a systematic review.Common GI Drug Interactions in the Elderly.
P2860
Q24195094-76795F81-8B0B-4682-8A92-5116636F674AQ24603675-07EF4DCD-4F6D-4A0A-964D-9C693E140B79Q26741015-AEF61CC2-7A3D-44A3-8920-2BF4F19D35E6Q27002566-A9C952EC-9C3A-407A-81A6-7345E03B8718Q28072141-C60D9C68-D2D5-4833-AF7D-65B20C94A2A1Q28396345-7A3FD6D5-8B3C-41DF-9EAA-484809B8B953Q30620638-5B305073-5165-4E53-8C8F-E7D564A54E3EQ33409626-EB7BEFE6-15CD-4A30-B0F0-7A9983CE7AC6Q34007345-13817D77-F18F-477F-A24A-8739B3090A04Q34320987-6A89AFDC-E322-4F32-ABF1-2C4A92A120D4Q34462037-38E9DF9C-CF12-48AF-B159-84477BF24698Q34625008-4365BD89-8AE4-4BC8-81DF-653392B5572AQ35013508-FAC03325-9DE4-4E7C-B613-E56F442FA165Q35072261-4F71ACA4-3A58-4E32-A84E-CE916E01BFADQ35158795-F7C3FC05-65B3-4EFC-BE3B-60517049886FQ35834504-407A975B-278F-4786-A2D2-8DAC4C1D530FQ35874733-7202C7E2-03C8-4ED2-897A-389A546EE176Q35989849-2F8518D6-900F-463B-9181-50ED703B06AFQ36075131-FCB9F7EC-48DC-4E2D-A684-AAA2C0930D3AQ36101677-4BDEC4D5-2C76-4BDF-A24B-69691FDA7C39Q36191241-B026D012-A0D1-4644-BE46-E87E466836A0Q36300366-A6256BCD-B892-49ED-BF8D-820ED08612C0Q36706785-C085E34C-D284-48C8-9156-89D6B972CF9EQ36822474-96593124-CEBC-40DF-9C0C-A9900AE93E74Q36990067-0532C336-1E70-4E03-835C-53148526769CQ37047798-988E9A20-9FB1-4B52-A548-0E82EE95719CQ37300872-D2D9ED0D-34BE-4121-977A-EC390E453ADDQ37378692-587E112C-DA25-4E43-A6BB-94A8823519CDQ37663683-E137C08C-4D1E-45DE-A7AB-F16F44C79DFCQ37740439-3239766D-2CC8-456A-AFD1-88551A1977E0Q37864149-23555F95-B993-41F4-B67C-54BAA53D7487Q37900222-84067A9D-E2D8-4908-A77A-40931326FED8Q37965678-DC093116-C126-41AB-A08C-89B700E1F824Q37987204-4374E88F-22E4-476A-B1AE-680E8185E6ADQ38001289-2CAB9D3B-FC4C-449F-87F1-2BCA5B4A03DCQ38011261-C40940A1-386A-45AC-B323-695E8C602F95Q38150165-35A5A96B-60B1-437C-9FAB-918A0BD049C7Q38198997-BD9CCB46-498A-4575-848F-96DC6B6AC610Q38208286-C8FA4B77-DB33-41A0-B454-8C2D729BFF79Q38230328-CBC52FF4-8A5C-4399-80C0-7C3F382DA0A1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety of proton pump inhibitor exposure.
@en
Safety of proton pump inhibitor exposure.
@nl
type
label
Safety of proton pump inhibitor exposure.
@en
Safety of proton pump inhibitor exposure.
@nl
prefLabel
Safety of proton pump inhibitor exposure.
@en
Safety of proton pump inhibitor exposure.
@nl
P1433
P1476
Safety of proton pump inhibitor exposure.
@en
P2093
David C Metz
Yu-Xiao Yang
P304
P356
10.1053/J.GASTRO.2010.08.023
P407
P577
2010-08-19T00:00:00Z